Market Tracker

02/21 2:04pm ET

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

3.98
Delayed Data
As of 1:37pm ET
 -0.1219 / -2.97%
Today’s Change
1.79
Today|||52-Week Range
5.29
+20.55%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close4.10
Today’s open4.05
Day’s range3.95 - 4.05
Volume22,504
Average volume (3 months)26,328
Market cap$62.1M
Dividend yield--
Data as of 1:37pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+75.22%
Earnings growth (next 5 years)--
Revenue growth (last year)+315.65%
P/E ratioNM
Price/Sales1.28
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TCONTRACON Pharmaceutica...-0.10-2.53%
RGLSRegulus Therapeutics...0.000.00%
CURRCure Pharmaceutical ...-0.40-15.38%
DRNADicerna Pharmaceutic...-0.01-0.34%
Data as of 1:59pm ET, 02/21/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$4.4M
Annual profit (last year)-$19.0M
Net profit margin-433.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer, Secretary &
Treasurer
Tom Paulson
Corporate headquarters
Emeryville, California

Forecasts